AU Stock MarketDetailed Quotes

Clarity Pharmaceuticals Ltd (CU6)

Watchlist
  • 3.320
  • -0.050-1.48%
20min DelayMarket Closed Jan 16 16:00 AET
1.24BMarket Cap-16.52P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Clarity Pharmaceuticals Ltd (CU6) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2025
(Q4)Jun 30, 2025
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-38.38%84.12M
-38.38%84.12M
109.96%136.51M
109.96%136.51M
-29.59%65.01M
-29.59%65.01M
--92.34M
--92.34M
-Cash and cash equivalents
-0.45%47.68M
-0.45%47.68M
53.46%47.9M
53.46%47.9M
-43.59%31.21M
-43.59%31.21M
--55.34M
--55.34M
-Short term investments
-58.88%36.43M
-58.88%36.43M
162.13%88.6M
162.13%88.6M
-8.64%33.8M
-8.64%33.8M
--37M
--37M
Receivables
-20.08%10.1M
-20.08%10.1M
26.32%12.63M
26.32%12.63M
50.24%10M
50.24%10M
--6.66M
--6.66M
-Other receivables
-20.08%10.1M
-20.08%10.1M
26.32%12.63M
26.32%12.63M
50.24%10M
50.24%10M
--6.66M
--6.66M
Prepaid assets
29.86%6.39M
29.86%6.39M
196.31%4.92M
196.31%4.92M
198.59%1.66M
198.59%1.66M
--556.21K
--556.21K
Total current assets
-34.70%100.61M
-34.70%100.61M
100.92%154.06M
100.92%154.06M
-22.98%76.68M
-22.98%76.68M
--99.55M
--99.55M
Non current assets
Net PPE
-0.42%552.46K
-0.42%552.46K
169.14%554.8K
169.14%554.8K
-20.74%206.14K
-20.74%206.14K
--260.09K
--260.09K
-Gross PPE
18.32%1.1M
18.32%1.1M
113.23%929.43K
113.23%929.43K
11.96%435.89K
11.96%435.89K
--389.32K
--389.32K
-Accumulated depreciation
-46.08%-547.26K
-46.08%-547.26K
-63.07%-374.63K
-63.07%-374.63K
-77.78%-229.74K
-77.78%-229.74K
---129.23K
---129.23K
Investments and advances
3.89%13.53K
3.89%13.53K
5.53%13.03K
5.53%13.03K
5.09%12.34K
5.09%12.34K
--11.75K
--11.75K
-Other investment
3.89%13.53K
3.89%13.53K
5.53%13.03K
5.53%13.03K
5.09%12.34K
5.09%12.34K
--11.75K
--11.75K
Total non current assets
-0.32%566K
-0.32%566K
159.89%567.83K
159.89%567.83K
-19.63%218.49K
-19.63%218.49K
--271.84K
--271.84K
Total assets
-34.57%101.17M
-34.57%101.17M
101.09%154.63M
101.09%154.63M
-22.97%76.9M
-22.97%76.9M
--99.82M
--99.82M
Liabilities
Current liabilities
Payables
22.64%8.53M
22.64%8.53M
3.25%6.96M
3.25%6.96M
-0.78%6.74M
-0.78%6.74M
--6.79M
--6.79M
-accounts payable
53.82%3.21M
53.82%3.21M
-26.77%2.08M
-26.77%2.08M
-0.11%2.85M
-0.11%2.85M
--2.85M
--2.85M
-Other payable
9.30%5.33M
9.30%5.33M
25.20%4.87M
25.20%4.87M
-1.26%3.89M
-1.26%3.89M
--3.94M
--3.94M
Pension and other retirement benefit plans
63.30%1.85M
63.30%1.85M
40.85%1.13M
40.85%1.13M
12.42%802.61K
12.42%802.61K
--713.93K
--713.93K
Other current liabilities
----
----
----
----
---1
---1
----
----
Current liabilities
28.32%10.38M
28.32%10.38M
7.25%8.09M
7.25%8.09M
0.48%7.54M
0.48%7.54M
--7.51M
--7.51M
Non current liabilities
Employee benefits
131.30%561.75K
131.30%561.75K
35.91%242.87K
35.91%242.87K
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Total non current liabilities
131.30%561.75K
131.30%561.75K
35.91%242.87K
35.91%242.87K
125.55%178.7K
125.55%178.7K
--79.23K
--79.23K
Total liabilities
31.32%10.94M
31.32%10.94M
7.91%8.33M
7.91%8.33M
1.78%7.72M
1.78%7.72M
--7.59M
--7.59M
Shareholders'equity
Share capital
2.58%255.89M
2.58%255.89M
87.81%249.45M
87.81%249.45M
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
-common stock
2.58%255.89M
2.58%255.89M
87.81%249.45M
87.81%249.45M
0.53%132.82M
0.53%132.82M
--132.12M
--132.12M
Retained earnings
-57.05%-176.99M
-57.05%-176.99M
-60.14%-112.7M
-60.14%-112.7M
-53.67%-70.37M
-53.67%-70.37M
---45.8M
---45.8M
Gains losses not affecting retained earnings
18.75%11.34M
18.75%11.34M
41.89%9.55M
41.89%9.55M
13.74%6.73M
13.74%6.73M
--5.92M
--5.92M
Total stockholders'equity
-38.32%90.23M
-38.32%90.23M
111.49%146.3M
111.49%146.3M
-25.00%69.18M
-25.00%69.18M
--92.24M
--92.24M
Total equity
-38.32%90.23M
-38.32%90.23M
111.49%146.3M
111.49%146.3M
-25.00%69.18M
-25.00%69.18M
--92.24M
--92.24M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(FY)Jun 30, 2025(Q4)Jun 30, 2025(FY)Jun 30, 2024(Q4)Jun 30, 2024(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -38.38%84.12M-38.38%84.12M109.96%136.51M109.96%136.51M-29.59%65.01M-29.59%65.01M--92.34M--92.34M
-Cash and cash equivalents -0.45%47.68M-0.45%47.68M53.46%47.9M53.46%47.9M-43.59%31.21M-43.59%31.21M--55.34M--55.34M
-Short term investments -58.88%36.43M-58.88%36.43M162.13%88.6M162.13%88.6M-8.64%33.8M-8.64%33.8M--37M--37M
Receivables -20.08%10.1M-20.08%10.1M26.32%12.63M26.32%12.63M50.24%10M50.24%10M--6.66M--6.66M
-Other receivables -20.08%10.1M-20.08%10.1M26.32%12.63M26.32%12.63M50.24%10M50.24%10M--6.66M--6.66M
Prepaid assets 29.86%6.39M29.86%6.39M196.31%4.92M196.31%4.92M198.59%1.66M198.59%1.66M--556.21K--556.21K
Total current assets -34.70%100.61M-34.70%100.61M100.92%154.06M100.92%154.06M-22.98%76.68M-22.98%76.68M--99.55M--99.55M
Non current assets
Net PPE -0.42%552.46K-0.42%552.46K169.14%554.8K169.14%554.8K-20.74%206.14K-20.74%206.14K--260.09K--260.09K
-Gross PPE 18.32%1.1M18.32%1.1M113.23%929.43K113.23%929.43K11.96%435.89K11.96%435.89K--389.32K--389.32K
-Accumulated depreciation -46.08%-547.26K-46.08%-547.26K-63.07%-374.63K-63.07%-374.63K-77.78%-229.74K-77.78%-229.74K---129.23K---129.23K
Investments and advances 3.89%13.53K3.89%13.53K5.53%13.03K5.53%13.03K5.09%12.34K5.09%12.34K--11.75K--11.75K
-Other investment 3.89%13.53K3.89%13.53K5.53%13.03K5.53%13.03K5.09%12.34K5.09%12.34K--11.75K--11.75K
Total non current assets -0.32%566K-0.32%566K159.89%567.83K159.89%567.83K-19.63%218.49K-19.63%218.49K--271.84K--271.84K
Total assets -34.57%101.17M-34.57%101.17M101.09%154.63M101.09%154.63M-22.97%76.9M-22.97%76.9M--99.82M--99.82M
Liabilities
Current liabilities
Payables 22.64%8.53M22.64%8.53M3.25%6.96M3.25%6.96M-0.78%6.74M-0.78%6.74M--6.79M--6.79M
-accounts payable 53.82%3.21M53.82%3.21M-26.77%2.08M-26.77%2.08M-0.11%2.85M-0.11%2.85M--2.85M--2.85M
-Other payable 9.30%5.33M9.30%5.33M25.20%4.87M25.20%4.87M-1.26%3.89M-1.26%3.89M--3.94M--3.94M
Pension and other retirement benefit plans 63.30%1.85M63.30%1.85M40.85%1.13M40.85%1.13M12.42%802.61K12.42%802.61K--713.93K--713.93K
Other current liabilities -------------------1---1--------
Current liabilities 28.32%10.38M28.32%10.38M7.25%8.09M7.25%8.09M0.48%7.54M0.48%7.54M--7.51M--7.51M
Non current liabilities
Employee benefits 131.30%561.75K131.30%561.75K35.91%242.87K35.91%242.87K125.55%178.7K125.55%178.7K--79.23K--79.23K
Total non current liabilities 131.30%561.75K131.30%561.75K35.91%242.87K35.91%242.87K125.55%178.7K125.55%178.7K--79.23K--79.23K
Total liabilities 31.32%10.94M31.32%10.94M7.91%8.33M7.91%8.33M1.78%7.72M1.78%7.72M--7.59M--7.59M
Shareholders'equity
Share capital 2.58%255.89M2.58%255.89M87.81%249.45M87.81%249.45M0.53%132.82M0.53%132.82M--132.12M--132.12M
-common stock 2.58%255.89M2.58%255.89M87.81%249.45M87.81%249.45M0.53%132.82M0.53%132.82M--132.12M--132.12M
Retained earnings -57.05%-176.99M-57.05%-176.99M-60.14%-112.7M-60.14%-112.7M-53.67%-70.37M-53.67%-70.37M---45.8M---45.8M
Gains losses not affecting retained earnings 18.75%11.34M18.75%11.34M41.89%9.55M41.89%9.55M13.74%6.73M13.74%6.73M--5.92M--5.92M
Total stockholders'equity -38.32%90.23M-38.32%90.23M111.49%146.3M111.49%146.3M-25.00%69.18M-25.00%69.18M--92.24M--92.24M
Total equity -38.32%90.23M-38.32%90.23M111.49%146.3M111.49%146.3M-25.00%69.18M-25.00%69.18M--92.24M--92.24M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -